<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Cell Biology - Most viewed articles</title>
		<link>http://www.biomedcentral.com/bmccellbiol/mostviewed/</link>
		<description>Most viewed articles in last 30 days from BMC Cell Biology (ISSN 1471-2121) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
         <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/35"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/33"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/13"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/34"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/30"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/36"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/24"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/32"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/37"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/9/31"/>			    
            
            </rdf:Seq>
        </items>
    </channel>
    
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/35">
            
            <title>Isolation of bacteria-containing phagosomes by magnetic selection</title>
			<description>Background:
There is a growing awareness of the importance of intracellular events in determining the outcome of infectious disease. To improve the understanding of such events, like phagosome maturation, we set out to develop a versatile technique for phagosome isolation that is rapid and widely applicable to different pathogens.
Results:
We developed two different protocols to isolate phagosomes containing dead or live bacteria modified with small magnetic particles, in conjunction with a synchronized phagocytosis protocol and nitrogen cavitation. For dead bacteria, we performed analysis of the phagosome samples by microscopy and immunoblot, and demonstrated the appearance of maturation markers on isolated phagosomes.
Conclusion:
We have presented detailed protocols for phagosome isolation, which can be adapted for use with different cell types and prey. The versatility and simplicity of the approach allow better control of phagosome isolation, the parameters of which are critical in studies of host-bacteria interaction and phagosome maturation.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/35</link>		
			<dc:creator>Per L&#246;nnbro, Pontus Nordenfelt and Hans Tapper</dc:creator>
			<dc:source>BMC Cell Biology 2008, 9:35</dc:source>
			<dc:subject>Number of accesses: 774</dc:subject>
			<dc:date>2008-06-27</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-35</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>35</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-27</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/33">
            
            <title>The influence of N-acetyl-L-cysteine on oxidative stress and nitric oxide synthesis in stimulated macrophages treated with a mustard gas analogue</title>
			<description>Background:
Sulphur mustard gas, 2, 2'-dichlorodiethyl sulphide (HD), is a chemical warfare agent. Both mustard gas and its monofunctional analogue, 2-chloroethyl ethyl sulphide (CEES), are alkylating agents that react with and diminish cellular thiols and are highly toxic. Previously, we reported that lipopolysaccharide (LPS) significantly enhances the cytotoxicity of CEES in murine RAW 264.7 macrophages and that CEES transiently inhibits nitric oxide (NO) production via suppression of inducible NO synthase (iNOS) protein expression. NO generation is an important factor in wound healing. In this paper, we explored the hypotheses that LPS increases CEES toxicity by increasing oxidative stress and that treatment with N-acetyl-L-cysteine (NAC) would block LPS induced oxidative stress and protect against loss of NO production. NAC stimulates glutathione (GSH) synthesis and also acts directly as a free radical scavenger. The potential therapeutic use of the antibiotic, polymyxin B, was also evaluated since it binds to LPS and could thereby block the enhancement of CEES toxicity by LPS and also inhibit the secondary infections characteristic of HD/CEES wounds.
Results:
We found that 10 mM NAC, when administered simultaneously or prior to treatment with 500 &#956;M CEES, increased the viability of LPS stimulated macrophages. Surprisingly, NAC failed to protect LPS stimulated macrophages from CEES induced loss of NO production. Macrophages treated with both LPS and CEES show increased oxidative stress parameters (cellular thiol depletion and increased protein carbonyl levels). NAC effectively protected RAW 264.7 cells simultaneously treated with CEES and LPS from GSH loss and oxidative stress. Polymyxin B was found to partially block nitric oxide production and diminish CEES toxicity in LPS-treated macrophages.
Conclusion:
The present study shows that oxidative stress is an important mechanism contributing to CEES toxicity in LPS stimulated macrophages and supports the notion that antioxidants could play a therapeutic role in preventing mustard gas toxicity. Although NAC reduced oxidative stress in LPS stimulated macrophages treated with CEES, it did not reverse CEES-induced loss of NO production. NAC and polymyxin B were found to help prevent CEES toxicity in LPS-treated macrophages.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/33</link>		
			<dc:creator>Victor Paromov, Min Qui, Hongsong Yang, Milton Smith and William L Stone</dc:creator>
			<dc:source>BMC Cell Biology 2008, 9:33</dc:source>
			<dc:subject>Number of accesses: 652</dc:subject>
			<dc:date>2008-06-20</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-33</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>33</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-20</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/13">
            
            <title>Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue</title>
			<description>Background:
Investigating the expression of candidate genes in tissue samples usually involves either immunohistochemical labelling of formalin-fixed paraffin-embedded (FFPE) sections or immunofluorescence labelling of cryosections. Although both of these methods provide essential data, both have important limitations as research tools. Consequently, there is a demand in the research community to be able to perform routine, high quality immunofluorescence labelling of FFPE tissues.
Results:
We present here a robust optimised method for high resolution immunofluorescence labelling of FFPE tissues, which involves the combination of antigen retrieval, indirect immunofluorescence and confocal laser scanning microscopy. We demonstrate the utility of this method with examples of immunofluorescence labelling of human kidney, human breast and a tissue microarray of invasive human breast cancers. Finally, we demonstrate that stained slides can be stored in the short term at 4&#176;C or in the longer term at -20&#176;C prior to images being collected. This approach has the potential to unlock a large in vivo database for immunofluorescence investigations and has the major advantages over immunohistochemistry in that it provides higher resolution imaging of antigen localization and the ability to label multiple antigens simultaneously.
Conclusion:
This method provides a link between the cell biology and pathology communities. For the cell biologist, it will enable them to utilise the vast archive of pathology specimens to advance their in vitro data into in vivo samples, in particular archival material and tissue microarrays. For the pathologist, it will enable them to utilise multiple antibodies on a single section to characterise particular cell populations or to test multiple biomarkers in limited samples and define with greater accuracy cellular heterogeneity in tissue samples.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/13</link>		
			<dc:creator>David Robertson, Kay Savage, Jorge S Reis-Filho and Clare M Isacke</dc:creator>
			<dc:source>BMC Cell Biology 2008, 9:13</dc:source>
			<dc:subject>Number of accesses: 545</dc:subject>
			<dc:date>2008-03-19</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-13</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>13</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-19</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/34">
            
            <title>Proteomic analysis of lamellar bodies isolated from rat lungs</title>
			<description>Background:
Lamellar bodies are lysosome-related secretory granules and store lung surfactant in alveolar type II cells. To better understand the mechanisms of surfactant secretion, we carried out proteomic analyses of lamellar bodies isolated from rat lungs.
Results:
With peptide mass fingerprinting by Matrix Assisted Laser Desorption/Ionization &#8211; Time of Flight mass spectrometry, 44 proteins were identified with high confidence. These proteins fell into diverse functional categories: surfactant-related, membrane trafficking, calcium binding, signal transduction, cell structure, ion channels, protein processing and miscellaneous. Selected proteins were verified by Western blot and immunohistochemistry.
Conclusion:
This proteomic profiling of lamellar bodies provides a basis for further investigations of functional roles of the identified proteins in lamellar body biogenesis and surfactant secretion.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/34</link>		
			<dc:creator>Pengcheng Wang, Narendranath Reddy Chintagari, Jeyaparthasarathy Narayanaperumal, Sahlu Ayalew, Steven Hartson and Lin Liu</dc:creator>
			<dc:source>BMC Cell Biology 2008, 9:34</dc:source>
			<dc:subject>Number of accesses: 497</dc:subject>
			<dc:date>2008-06-24</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-34</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>34</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-24</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/30">
            
            <title>Rapid preparation of nuclei-depleted detergent-resistant membrane fractions suitable for proteomics analysis</title>
			<description>Background:
Cholesterol-rich membrane microdomains known as lipid rafts have been implicated in diverse physiologic processes including lipid transport and signal transduction. Lipid rafts were originally defined as detergent-resistant membranes (DRMs) due to their relative insolubility in cold non-ionic detergents. Recent findings suggest that, although DRMs are not equivalent to lipid rafts, the presence of a given protein within DRMs strongly suggests its potential for raft association in vivo. Therefore, isolation of DRMs represents a useful starting point for biochemical analysis of lipid rafts. The physicochemical properties of DRMs present unique challenges to analysis of their protein composition. Existing methods of isolating DRM-enriched fractions involve flotation of cell extracts in a sucrose density gradient, which, although successful, can be labor intensive, time consuming and results in dilute sucrose-containing fractions with limited utility for direct proteomic analysis. In addition, several studies describing the proteomic characterization of DRMs using this and other approaches have reported the presence of nuclear proteins in such fractions. It is unclear whether these results reflect trafficking of nuclear proteins to DRMs or whether they arise from nuclear contamination during isolation. To address these issues, we have modified a published differential detergent extraction method to enable rapid DRM isolation that minimizes nuclear contamination and yields fractions compatible with mass spectrometry.
Results:
DRM-enriched fractions isolated using the conventional or modified extraction methods displayed comparable profiles of known DRM-associated proteins, including flotillins, GPI-anchored proteins and heterotrimeric G-protein subunits. Thus, the modified procedure yielded fractions consistent with those isolated by existing methods. However, we observed a marked reduction in the percentage of nuclear proteins identified in DRM fractions isolated with the modified method (15%) compared to DRMs isolated by conventional means (36%). Furthermore, of the 21 nuclear proteins identified exclusively in modified DRM fractions, 16 have been reported to exist in other subcellular sites, with evidence to suggest shuttling of these species between the nucleus and other organelles.
Conclusion:
We describe a modified DRM isolation procedure that generates DRMs that are largely free of nuclear contamination and that is compatible with downstream proteomic analyses with minimal additional processing. Our findings also imply that identification of nuclear proteins in DRMs is likely to reflect legitimate movement of proteins between compartments, and is not a result of contamination during extraction.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/30</link>		
			<dc:creator>Rosalyn M Adam, Wei Yang, Dolores Di Vizio, Nishit K Mukhopadhyay and Hanno Steen</dc:creator>
			<dc:source>BMC Cell Biology 2008, 9:30</dc:source>
			<dc:subject>Number of accesses: 460</dc:subject>
			<dc:date>2008-06-05</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-30</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>30</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-05</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/36">
            
            <title>Kindlin-2 is required for myocyte elongation and is essential for myogenesis</title>
			<description>Background:
Integrins are required for normal muscle differentiation and disruptions in integrin signaling result in human muscle disease. The intracellular components that regulate integrin function during myogenesis are poorly understood. Unc-112 is an integrin-associated protein required for muscle development in C. elegans. To better understand the intracellular effectors of integrin signaling in muscle, we examined the mammalian homolog of Unc-112, kindlin-2.
Results:
Kindlin-2 expression is upregulated during differentiation and highly enriched at sites of integrin localization. RNAi knockdown of kindlin-2 in C2C12 cells results in significant abnormalities during the early stages of myogenesis. Specifically, differentiating myocytes lacking kindlin-2 are unable to elongate and fail to fuse into multinucleated myotubes. These changes are correlated with decreased cell substratum adhesion and increased cell motility. They are also associated with redistribution of a known kindlin-2 binding partner, integrin linked kinase (ILK), to the membrane insoluble subcellular fraction.
Conclusion:
In all, our study reveals kindlin-2 as a novel integrin adaptor protein important for muscle differentiation, and identifies it particularly as a critical regulator of myocyte elongation.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/36</link>		
			<dc:creator>James J Dowling, Andrew P Vreede, Susie Kim, Jeffrey Golden and Eva L Feldman</dc:creator>
			<dc:source>BMC Cell Biology 2008, 9:36</dc:source>
			<dc:subject>Number of accesses: 435</dc:subject>
			<dc:date>2008-07-08</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-36</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>36</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-08</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/24">
            
            <title>Comparative study of mesenchymal stem cells from C57BL/10 and mdx mice</title>
			<description>Background:
Human mesenchymal stem cells (MSCs) have been studied and applied extensively because of their ability to self-renew and differentiate into various cell types. Since most human diseases models are murine, mouse MSCs should have been studied in detail. The mdx mouse &#8211; a Duchenne muscular dystrophy model &#8211; was produced by introducing a point mutation in the dystrophin gene. To understand the role of dystrophin in MSCs, we compared MSCs from mdx and C57BL/10 mice, focusing particularly on the aspects of light and electron microscopic morphology, immunophenotyping, and differentiation potential.
Results:
Our study showed that at passage 10, mdx-MSCs exhibited increased heterochromatin, larger vacuoles, and more lysosomes under electron microscopy compared to C57BL/10-MSCs. C57BL/10-MSCs formed a few myotubes, while mdx-MSCs did not at the same passages. By passage 21, mdx-MSCs but not C57BL/10-MSCs had gradually lost their proliferative ability. In addition, a significant difference in the expression of CD34, not Sca-1 and CD11b, was observed between the MSCs from the 2 mice.
Conclusion:
Our current study reveals that the MSCs from the 2 mice, namely, C57BL/10 and mdx, exhibit differences in proliferative and myogenic abilities. The results suggest that the changes in mouse MSC behavior may be influenced by lack of dystrophin protein in mdx mouse.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/24</link>		
			<dc:creator>Yong Li, Cheng Zhang, Fu Xiong, Mei-juan Yu, Fu-lin Peng, Yan-chang Shang, Cui-ping Zhao, Yong-feng Xu, Zheng-shan Liu, Chang Zhou and Jin-lang Wu</dc:creator>
			<dc:source>BMC Cell Biology 2008, 9:24</dc:source>
			<dc:subject>Number of accesses: 397</dc:subject>
			<dc:date>2008-05-19</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-24</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>24</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-19</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/32">
            
            <title>The HIV Tat protein affects processing of ribosomal RNA precursor</title>
			<description>Background:
Inside the cell, the HIV Tat protein is mainly found in the nucleus and nucleolus. The nucleolus, the site of ribosome biogenesis, is a highly organized, non-membrane-bound sub-compartment where proteins with a high affinity for nucleolar components are found. While it is well known that Tat accumulates in the nucleolus via a specific nucleolar targeting sequence, its function in this compartment it still unknown.
Results:
To clarify the significance of the Tat nucleolar localization, we induced the expression of the protein during oogenesis in Drosophila melanogaster strain transgenic for HIV-tat gene. Here we show that Tat localizes in the nucleoli of Drosophila oocyte nurse cells, where it specifically co-localizes with fibrillarin. Tat expression is accompanied by a significant decrease of cytoplasmic ribosomes, which is apparently related to an impairment of ribosomal rRNA precursor processing. Such an event is accounted for by the interaction of Tat with fibrillarin and U3 snoRNA, which are both required for pre-rRNA maturation.
Conclusion:
Our data contribute to understanding the function of Tat in the nucleolus, where ribosomal RNA synthesis and cell cycle control take place. The impairment of nucleolar pre-rRNA maturation through the interaction of Tat with fibrillarin-U3snoRNA complex suggests a process by which the virus modulates host response, thus contributing to apoptosis and protein shut-off in HIV-uninfected cells.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/32</link>		
			<dc:creator>Donatella Ponti, Maria Troiano, Gian Carlo Bellenchi, Piero A Battaglia and Franca Gigliani</dc:creator>
			<dc:source>BMC Cell Biology 2008, 9:32</dc:source>
			<dc:subject>Number of accesses: 388</dc:subject>
			<dc:date>2008-06-17</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-32</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>32</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/37">
            
            <title>The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response</title>
			<description>Background:
FUS, EWS and TAF15 are structurally similar multifunctional proteins that were first discovered upon characterization of fusion oncogenes in human sarcomas and leukemias. The proteins belong to the FET (previously TET) family of RNA-binding proteins and are implicated in central cellular processes such as regulation of gene expression, maintenance of genomic integrity and mRNA/microRNA processing. In the present study, we investigated the expression and cellular localization of FET proteins in multiple human tissues and cell types.
Results:
FUS, EWS and TAF15 were expressed in both distinct and overlapping patterns in human tissues. The three proteins showed almost ubiquitous nuclear expression and FUS and TAF15 were in addition present in the cytoplasm of most cell types. Cytoplasmic EWS was more rarely detected and seen mainly in secretory cell types. Furthermore, FET expression was downregulated in differentiating human embryonic stem cells, during induced differentiation of neuroblastoma cells and absent in terminally differentiated melanocytes and cardiac muscle cells. The FET proteins were targeted to stress granules induced by heat shock and oxidative stress and FUS required its RNA-binding domain for this translocation. Furthermore, FUS and TAF15 were detected in spreading initiation centers of adhering cells.
Conclusion:
Our results point to cell-specific expression patterns and functions of the FET proteins rather than the housekeeping roles inferred from earlier studies. The localization of FET proteins to stress granules suggests activities in translational regulation during stress conditions. Roles in central processes such as stress response, translational control and adhesion may explain the FET proteins frequent involvement in human cancer.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/37</link>		
			<dc:creator>Mattias K Andersson, Anders St&#229;hlberg, Yvonne Arvidsson, Anita Olofsson, Henrik Semb, G&#246;ran Stenman, Ola Nilsson and Pierre &#197;man</dc:creator>
			<dc:source>BMC Cell Biology 2008, 9:37</dc:source>
			<dc:subject>Number of accesses: 369</dc:subject>
			<dc:date>2008-07-11</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-37</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>37</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-11</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2121/9/31">
            
            <title>Mechanism of nuclear factor of activated T-cells mediated FasL expression in corticosterone -treated mouse Leydig tumor cells</title>
			<description>Background:
Fas and FasL is important mediators of apoptosis. We have previously reported that the stress levels of corticosterone (CORT, glucocorticoid in rat) increase expression of Fas/FasL and activate Fas/FasL signal pathway in rat Leydig cells, which consequently leads to apoptosis. Moreover, our another study showed that nuclear factor of activated T-cells (NFAT) may play a potential role in up-regulation of FasL during CORT-treated rat Leydig cell. It is not clear yet how NFAT is involved in CORT-induced up-regulation of FasL. The aim of the present study is to investigate the molecular mechanisms of NFAT-mediated FasL expression in CORT-treated Leydig cells.
Results:
Western blot analysis showed that NFAT2 expression is present in mouse Leydig tumor cell (mLTC-1). CORT-induced increase in FasL expression in mLTC-1 was ascertained by Western Blot analysis and CORT-induced increase in apoptotic frequency of mLTC-1 cells was detected by FACS with annexin-V labeling. Confocal imaging of NFAT2-GFP in mLTC-1 showed that high level of CORT stimulated NFAT translocation from the cytoplasm to the nucleus. RNA interference-mediated knockdown of NFAT2 significantly attenuated CORT-induced up-regulation of FasL expression in mLTC. These results corroborated our previous finding that NFAT2 is involved in CORT-induced FasL expression in rat Leydig cells and showed that mLTC-1 is a suitable model for investigating the mechanism of CORT-induced FasL expression. The analysis of reporter constructs revealed that the sequence between -201 and +71 of mouse FasL gene is essential for CORT-induced FasL expression. The mutation analysis demonstrated that CORT-induced FasL expression is mediated via an NFAT binding element located in the -201 to +71 region. Co-transfection studies with an NFAT2 expression vector and reporter construct containing -201 to +71 region of FasL gene showed that NFAT2 confer a strong inducible activity to the FasL promoter at its regulatory region. In addition, chromatin immunoprecipitation assay further confirmed the results of reporter gene studies by showing the specific binding of NFAT2 to the -201 to +71 region.
Conclusion:
In the present study, we demonstrated that NFAT2 directly stimulates transcription of FasL in high level CORT-treated mLTC-1. In conclusion, the present study provides further evidence for our finding that CORT-induced FasL expression in Leydig cells is mediated by NFAT.</description>
			<link>http://www.biomedcentral.com/1471-2121/9/31</link>		
			<dc:creator>Wei-Ran Chai, Yong Chen, Qian Wang and Hui-Bao Gao</dc:creator>
			<dc:source>BMC Cell Biology 2008, 9:31</dc:source>
			<dc:subject>Number of accesses: 365</dc:subject>
			<dc:date>2008-06-12</dc:date>
			<dc:identifier>doi:10.1186/1471-2121-9-31</dc:identifier>
			
			
							
					<prism:publicationName>BMC Cell Biology</prism:publicationName>
					
			
							
					<prism:issn>1471-2121</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>31</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
	<cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
